# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010152
Filing Date
2023-03-31
Accepted
2023-03-31 15:03:21
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1518881
2 |  | form10-k_001.jpg | GRAPHIC | 32530
3 |  | form10-k_002.jpg | GRAPHIC | 16992
4 |  | form10-k_003.jpg | GRAPHIC | 28110
5 |  | form10-k_004.jpg | GRAPHIC | 23881
6 |  | ex4-1.htm | EX-4.1 | 38711
7 |  | ex21-1.htm | EX-21.1 | 3428
8 |  | ex31-1.htm | EX-31.1 | 20467
9 |  | ex31-2.htm | EX-31.2 | 20691
10 |  | ex99-1.htm | EX-99.1 | 40877
11 |  | ex99-2.htm | EX-99.2 | 36114
12 |  | ex99-3.htm | EX-99.3 | 18331
| Complete submission text file | 0001493152-23-010152.txt |  | 5531841

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | ptix-20221231.xsd | EX-101.SCH | 33907
14 | XBRL CALCULATION FILE | ptix-20221231_cal.xml | EX-101.CAL | 48182
15 | XBRL DEFINITION FILE | ptix-20221231_def.xml | EX-101.DEF | 166218
16 | XBRL LABEL FILE | ptix-20221231_lab.xml | EX-101.LAB | 323512
17 | XBRL PRESENTATION FILE | ptix-20221231_pre.xml | EX-101.PRE | 241443
57 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 552299

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12555 | Film No.: 23786889
SIC: 2834 Pharmaceutical Preparations